16 related articles for article (PubMed ID: 38517408)
1. Hepatoprotective Effects of Bioflavonoid Luteolin Using Self-Nanoemulsifying Drug Delivery System.
Shakeel F; Alamer MM; Alam P; Alshetaili A; Haq N; Alanazi FK; Alshehri S; Ghoneim MM; Alsarra IA
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946581
[TBL] [Abstract][Full Text] [Related]
2. Binary Nanodrug-Delivery System Designed for Leukemia Therapy: Aptamer- and Transferrin-Codecorated Daunorubicin- and Luteolin-Coloaded Nanoparticles.
Zhu Y; Zhang W; Chen J
Drug Des Devel Ther; 2023; 17():1-13. PubMed ID: 36636745
[TBL] [Abstract][Full Text] [Related]
3. Delivery luteolin with folacin-modified nanoparticle for glioma therapy.
Wu C; Xu Q; Chen X; Liu J
Int J Nanomedicine; 2019; 14():7515-7531. PubMed ID: 31571861
[TBL] [Abstract][Full Text] [Related]
4. Luteolin and Gemcitabine Protect Against Pancreatic Cancer in an Orthotopic Mouse Model.
Johnson JL; Dia VP; Wallig M; Gonzalez de Mejia E
Pancreas; 2015 Jan; 44(1):144-51. PubMed ID: 25237909
[TBL] [Abstract][Full Text] [Related]
5. Mucoadhesive nanoemulsion enhances brain bioavailability of luteolin after intranasal administration and induces apoptosis to SH-SY5Y neuroblastoma cells.
Diedrich C; Camargo Zittlau I; Schineider Machado C; Taise Fin M; Maissar Khalil N; Badea I; Mara Mainardes R
Int J Pharm; 2022 Oct; 626():122142. PubMed ID: 36064075
[TBL] [Abstract][Full Text] [Related]
6. Self-assembled nanomicelles for oral delivery of luteolin utilizing the intestinal lymphatic pathway to target pancreatic cancer.
Karole A; Dinakar YH; Sagar P; Mudavath SL
Nanoscale; 2024 Apr; 16(15):7453-7466. PubMed ID: 38517408
[TBL] [Abstract][Full Text] [Related]
7. Targeting the intestinal lymphatic system: a versatile path for enhanced oral bioavailability of drugs.
Managuli RS; Raut SY; Reddy MS; Mutalik S
Expert Opin Drug Deliv; 2018 Aug; 15(8):787-804. PubMed ID: 30025212
[TBL] [Abstract][Full Text] [Related]
8.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
